{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:23:58Z","timestamp":1773282238815,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s12325-009-0042-5","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T09:38:26Z","timestamp":1246354706000},"page":"645-650","source":"Crossref","is-referenced-by-count":12,"title":["Aqueous prostaglandin E2 of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing"],"prefix":"10.1007","volume":"26","author":[{"suffix":"Jr.","given":"Frank A.","family":"Bucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. David","family":"Waterbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"42_CR1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2165\/00003495-200767090-00004","volume":"67","author":"J. Colin","year":"2007","unstructured":"Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs. 2007;67:1291\u20131308.","journal-title":"Drugs"},{"key":"42_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9394(98)00413-9","volume":"127","author":"J. Heier","year":"1999","unstructured":"Heier J, Cheetham JK, Degryse R et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol. 1999;127:253\u2013259.","journal-title":"Am J Ophthalmol"},{"key":"42_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0886-3350(01)01185-3","volume":"28","author":"M.P. Holzer","year":"2002","unstructured":"Holzer MP, Solomon KD, Sandoval HP, Vroman DT. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study. J Cataract Refract Surg. 2002;28:93\u201399.","journal-title":"J Cataract Refract Surg"},{"key":"42_CR4","first-page":"661","volume":"15","author":"R.K. Rajpal","year":"1999","unstructured":"Rajpal RK, Cooperman BB. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group. J Refract Surg. 1999;15:661\u2013667.","journal-title":"Ketorolac Study Group. J Refract Surg"},{"key":"42_CR5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/S0886-3350(00)00832-4","volume":"27","author":"K.D. Solomon","year":"2001","unstructured":"Solomon KD, Vroman DT, Barker D, Gehlken J. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. J Cataract Refract Surg. 2001;27:1232\u20131237.","journal-title":"J Cataract Refract Surg"},{"key":"42_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/14656566.7.1.99","volume":"7","author":"H.D. Perry","year":"2006","unstructured":"Perry HD, Donnenfeld ED. An update on the use of ophthalmic ketorolac tromethamine 0.4%. Expert Opin Pharmacother. 2006;7:99\u2013107.","journal-title":"Expert Opin Pharmacother"},{"key":"42_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jcrs.2006.04.009","volume":"32","author":"E.D. Donnenfeld","year":"2006","unstructured":"Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32:1474\u20131482.","journal-title":"J Cataract Refract Surg"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3928\/1081-597X-20020301-07","volume":"18","author":"F.W. Price Jr.","year":"2002","unstructured":"Price FW, Jr., Price MO, Zeh W, Dobbins K. Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebocontrolled trial. J Refract Surg. 2002;18:140\u2013144.","journal-title":"J Refract Surg"},{"key":"42_CR9","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1185\/030079904X16759","volume":"20","author":"M.O. Price","year":"2004","unstructured":"Price MO, Price FW. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin. 2004;20:2015\u20132019.","journal-title":"Curr Med Res Opin"},{"key":"42_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/jop.2006.22.251","volume":"22","author":"H.P. Sandoval","year":"2006","unstructured":"Sandoval HP, F\u00e9rnandez De Castro LE, Vroman DT, Solomon KD. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. J Ocul Pharmacol Ther. 2006;22:251\u2013257.","journal-title":"J Ocul Pharmacol Ther"},{"key":"42_CR11","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.jcrs.2004.05.019","volume":"30","author":"K.D. Solomon","year":"2004","unstructured":"Solomon KD, Donnenfeld ED, Raizman M et al. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. J Cataract Refract Surg. 2004;30:1653\u20131660.","journal-title":"J Cataract Refract Surg"},{"key":"42_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ajo.2008.04.036","volume":"146","author":"J.R. Wittpenn","year":"2008","unstructured":"Wittpenn JR, Silverstein S, Heier J et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008;146:554\u2013560.","journal-title":"Am J Ophthalmol"},{"key":"42_CR13","unstructured":"Xibrom [package insert]. Irvine, CA, USA: ISTA Pharmaceuticals, Inc.; 2006."},{"key":"42_CR14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ophtha.2006.12.029","volume":"114","author":"E.D. Donnenfeld","year":"2007","unstructured":"Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR, Bromfenac OPhthalmic Solution (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology. 2007;114:1653\u20131662.","journal-title":"Ophthalmology"},{"key":"42_CR15","unstructured":"Acular LS [package insert]. Irvine, CA, USA: Allergan, Inc.; 2003."},{"key":"42_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/bjo.80.5.480","volume":"80","author":"P. Koay","year":"1996","unstructured":"Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol. 1996;80:480\u2013485.","journal-title":"Br J Ophthalmol"},{"key":"42_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1096\/fj.03-0645rev","volume":"18","author":"T.D. Warner","year":"2004","unstructured":"Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004;18:790\u2013804.","journal-title":"FASEB J"},{"key":"42_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jcrs.2008.05.023","volume":"34","author":"F.A. Bucci Jr.","year":"2008","unstructured":"Bucci FA Jr., Waterbury LD. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels. J Cataract Refract Surg. 2008;34:1509\u20131512.","journal-title":"J Cataract Refract Surg"},{"key":"42_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/ICU.0b013e3282f30577","volume":"19","author":"F.C. Decroos","year":"2008","unstructured":"Decroos FC, Afshari NA. Perioperative antibiotics and anti-inflammatory agents in cataract surgery. Curr Opin Ophthalmol. 2008;19:22\u201326.","journal-title":"Curr Opin Ophthalmol"},{"key":"42_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ajo.2007.02.034","volume":"144","author":"F.A. Bucci Jr.","year":"2007","unstructured":"Bucci FA Jr., Waterbury LD, Amico LM. Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (Acular LS) and nepafenac 0.1% (Nevanac) in patients undergoing phacoemulsification. Am J Ophthalmol. 2007;144:146\u2013147.","journal-title":"Am J Ophthalmol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0042-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0042-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0042-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0042-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:08:37Z","timestamp":1633651717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0042-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0042-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}